Cycle of fasting and feeding is crucial for healthy ageing

Killifish age in fast motion. The bright colours of their youth fade after just a few months.
© Katharina Link / Max Planck Institute for Biology of Ageing

Genetic switch rescues old fish from fasting trap.

Health is thought to be improved by fasting interventions, which involve alternating periods of fasting and feeding. But this doesn’t work as well in old animals. By studying the short-lived killifish, researchers at the Max Planck Institute for Biology of Ageing in Cologne have shown that older fish deviate from a youthful fast and refeed cycle, and instead enter a state of perpetual fasting, even when feeding. However, the benefits of refeeding after fasting in old killifish can be restored by genetically activating a specific subunit of AMP kinase. These fish experienced improved health and longevity, indicating that both fasting and refeeding are needed to confer health benefits.

It has already been shown in many model organisms that a reduced diet, either through calorie restriction or periods of fasting, has a positive effect on health. However, it is difficult for humans to eat less throughout life. In order to find the most opportune timing to fasting, researchers introduced fasting interventions at different ages, finding that these interventions in older age do not yield the same benefits as they do in younger animals.

A team of researchers from Cologne, Germany, has now investigated the age-related fasting effects in killifish. Killifish are rapid-aging fish that go from young to old in just a few months. The researchers either fasted young and old fish for a few days or fed them twice a day. They found that the visceral adipose (fat) tissue of old fish became less responsive to feeding. “The adipose tissue is known to react most strongly to variations in food intake and has an important role in metabolism. That’s why we looked at it more closely,” explains Roberto Ripa, lead author of the study.

Alternation between fasting and eating is crucial

The researchers found that the inability to respond to the feeding phase set the fat tissue of old fish in a permanent state of fasting: energy metabolism is shut down, protein production is reduced, and tissue is not renewed. “We had assumed that old fish would not be able to switch to fasting after feeding. Surprisingly, the opposite was true, the old fish were in a permanent fasting state, even while eating food” says Adam Antebi, Director at the Max Planck Institute for Biology of Ageing and leader of the study.

Adipose tissue in a permanent fasting state

When the researchers looked more closely at how the fatty tissue of the old fish differed from that of the young, they came across a specific protein called AMP kinase. This kinase is a cellular energy sensor, and is made up of different subunits, of which the activity of the γ1 subunit decreases with age. When the scientists increased the activity of this subunit through genetic modification, the fasting-like state was counteracted and the old fish were healthier and even lived longer.

Human ageing

Interestingly, a link was also found between the γ1-subunit and human ageing. Significantly lower levels of the particular subunit were measured in samples from elderly patients. In addition, it was possible to show in the human samples: the less frail a person is in old age, the higher the level of the γ1-subunit.

“Of course, we don’t yet know whether in humans the γ1-subunit is actually responsible for healthier ageing. In the next step, we will try to find molecules that activate precisely this subunit and investigate whether we can use them to positively influence ageing,” explains Adam Antebi.

The research for this study was conducted at the Max Planck Institute for Biology of Ageing and was co-funded by the CECAD Cluster of Excellence for Aging Research.

Wissenschaftliche Ansprechpartner:

Prof. Dr. Adam Antebi, Max Planck Director, Max Planck Institute for Biology of Ageing, aantebi@age.mpg.de

Originalpublikation:

Roberto Ripa, Eugene Ballhysa, Joachim D. Steiner, Raymond Laboy, Andrea Annibal, Nadine Hochhard, Christian Latza, Luca Dolfi, Chiara Calabrese, Anna M. Meyer, Maria Cristina Polidori, Roman-Ulrich Müller, Adam Antebi
Refeeding-associated AMPKγ1 complex activity is a hallmark of health and longevity
Nature Ageing, 10 November 2023
https://www.nature.com/articles/s43587-023-00521-y

Weitere Informationen:

https://www.age.mpg.de/faq-ageing
https://www.age.mpg.de/antebi

http://www.age.mpg.de

Media Contact

Dr. Maren Berghoff Communications
Max-Planck-Institut für Biologie des Alterns

All latest news from the category: Life Sciences and Chemistry

Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.

Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.

Back to home

Comments (0)

Write a comment

Newest articles

Urban stormwater detention basin affected by salt pollution and salt-tolerant plants

Going Green: Fighting Freshwater Salt Pollution with Phytoremediation

Salt pollution in freshwater is a growing global concern. Excessive salt harms plants, degrades soil, and compromises water quality. In urban areas, road salts used for de-icing during winter often…

Illustration of leaky gut and inflammation in psoriasis research

Psoriasis Patients at Increased Risk for Crohn’s Due to Gut Inflammation

People with the skin condition psoriasis often have invisible inflammation in the small intestine with an increased propensity for ‘leaky gut’, according to new research at Uppsala University. These changes…

Vials of GLP-1 receptor agonist drugs illustrating benefits and potential risks

Popular Weight-Loss Drugs—Beneficial or Risky?

GLP-1 medications tied to decreased risk of dementia, addiction; increased risk of kidney, pancreas and gastrointestinal problems Growing Public Demand for GLP-1RA Weight-Loss Medications Demand for weight-loss medications sold under…